First Time Loading...

Immunome Inc
NASDAQ:IMNM

Watchlist Manager
Immunome Inc Logo
Immunome Inc
NASDAQ:IMNM
Watchlist
Price: 17.18 USD -1.15% Market Closed
Updated: Apr 19, 2024

Wall Street
Price Targets

IMNM Price Targets Summary
Immunome Inc

Wall Street analysts forecast IMNM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMNM is 36.04 USD with a low forecast of 33.33 USD and a high forecast of 39.9 USD.

Lowest
Price Target
33.33 USD
94% Upside
Average
Price Target
36.04 USD
110% Upside
Highest
Price Target
39.9 USD
132% Upside

IMNM Last Price Targets
Immunome Inc

The latest public price target was made on Apr 15, 2024 by Michael Schmidt from Guggenheim , who expects IMNM stock to rise by 104% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Michael Schmidt
Guggenheim
35 USD
Upside 104%
4 days ago
Apr 15, 2024
Immunome initiated with a Buy at Guggenheim
TheFly
David Nierengarten
Wedbush
33 USD
Upside 92%
2 weeks ago
Apr 1, 2024
Immunome price target raised to $33 from $27 at Wedbush
TheFly
Michael Schmidt
Guggenheim
Price Target 35 USD
Upside/Downside 104%
View Source
David Nierengarten
Wedbush
Price Target 33 USD
Upside/Downside 92%
View Source
Immunome Inc Competitors:
Price Targets
688276
Changchun BCHT Biotechnology Co
73% Upside
SABS
SAB Biotherapeutics Inc
312% Upside
600201
Jinyu Bio-Technology Co Ltd
14% Upside
NTLA
Intellia Therapeutics Inc
243% Upside
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
57% Upside
CDMO
Avid Bioservices Inc
96% Upside
TLSA
Tiziana Life Sciences Ltd
378% Upside
HRTX
Heron Therapeutics Inc
163% Upside

Revenue
Forecast

Revenue Estimate
Immunome Inc

The compound annual growth rate of Immunome Inc's revenue for the next 3 years is -10%.

N/A
Past Growth
-10%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Immunome Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Immunome Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-81%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMNM's stock price target?
Price Target
36.04 USD

According to Wall Street analysts, the average 1-year price target for IMNM is 36.04 USD with a low forecast of 33.33 USD and a high forecast of 39.9 USD.

What is Immunome Inc's Revenue forecast?
Projected CAGR
-10%

The compound annual growth rate of Immunome Inc's revenue for the next 3 years is -10%.